Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,694 | -103,916 | -55,577 | -29,991 | -8,047 |
| Depreciation Amortization | 7,767 | 6,318 | 1,289 | 684 | 240 |
| Accounts payable and accrued liabilities | 2,459 | -4,452 | 4,383 | 1,720 | 518 |
| Other Working Capital | 11,520 | 463 | 10,565 | 34,718 | 929 |
| Other Operating Activity | 12,616 | 10,229 | -3,222 | -652 | -2,124 |
| Operating Cash Flow | $-94,332 | $-91,358 | $-42,562 | $6,479 | $-8,484 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 208,629 | -29,966 | -96,848 | -78,071 | N/A |
| PPE Investments | -3,733 | -21,833 | -24,939 | -1,958 | -1,989 |
| Other Investing Activity | 0 | 0 | 0 | -1,497 | -276 |
| Investing Cash Flow | $204,896 | $-51,799 | $-121,787 | $-81,526 | $-2,265 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 53,093 | 158,213 | 150,994 | 0 | 378 |
| Common Stock Repurchased | N/A | N/A | N/A | -17 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 115,247 | 0 |
| Financing Cash Flow | $53,093 | $158,213 | $150,994 | $115,230 | $378 |
| Beginning Cash Position | 55,048 | 39,992 | 53,347 | 11,392 | 21,763 |
| End Cash Position | 218,705 | 55,048 | 39,992 | 51,575 | 11,392 |
| Net Cash Flow | $163,657 | $15,056 | $-13,355 | $40,183 | $-10,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,332 | -91,358 | -42,562 | 6,479 | -8,484 |
| Capital Expenditure | -3,733 | -21,833 | -24,939 | -1,958 | -1,989 |
| Free Cash Flow | -98,065 | -113,191 | -67,501 | 4,521 | -10,473 |